A detailed history of Norges Bank transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Norges Bank holds 100,000 shares of WVE stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Holding current value
$1.09 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$8.0 - $16.44 $800,000 - $1.64 Million
100,000 New
100,000 $1.24 Million
Q2 2019

Aug 09, 2019

SELL
$22.93 - $42.84 $1.15 Million - $2.14 Million
-50,000 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$32.69 - $47.91 $1.63 Million - $2.4 Million
50,000 New
50,000 $1.94 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $944M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.